Cargando…

A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms

OBJECTIVES: Geffer effervescent granules (active ingredients: metoclopramide, dimethicone, and sodium bicarbonate) is an established over-the-counter medication available in Italy for the symptomatic treatment of hyperacidity (pain and/or heartburn) when accompanied by slowing of gastric transit, na...

Descripción completa

Detalles Bibliográficos
Autores principales: Alemanni, Matteo, de Salvo, Raffaella, Moroni, Barbara, Ehret, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968989/
https://www.ncbi.nlm.nih.gov/pubmed/35371486
http://dx.doi.org/10.1177/20503121221088815
_version_ 1784679163385348096
author Alemanni, Matteo
de Salvo, Raffaella
Moroni, Barbara
Ehret, Andreas
author_facet Alemanni, Matteo
de Salvo, Raffaella
Moroni, Barbara
Ehret, Andreas
author_sort Alemanni, Matteo
collection PubMed
description OBJECTIVES: Geffer effervescent granules (active ingredients: metoclopramide, dimethicone, and sodium bicarbonate) is an established over-the-counter medication available in Italy for the symptomatic treatment of hyperacidity (pain and/or heartburn) when accompanied by slowing of gastric transit, nausea, aerophagia, and bloating, all symptoms that can occur in functional dyspepsia and can negatively impact individuals’ quality of life. The aim of this observational study was to explore the perceived benefits of, and consumer experience with, Geffer effervescent granules used for the symptomatic treatment of digestive disorders suggestive of functional dyspepsia under real-life conditions in Italy. METHODS: Adults (aged 35–65 years) experiencing symptoms suggestive of functional dyspepsia/indigestion at least once a month and who had used Geffer effervescent granules within the previous 6 months completed an online questionnaire eliciting information on symptom relief (speed of onset and duration) and quality of life. RESULTS: Geffer effervescent granules provided rapid onset of symptom relief, with 21% of respondents perceiving an effect within 10 min and 88% reporting an improvement in overall symptoms within 30 min. A similarly rapid onset of complete resolution of gastric pain/cramps, acidity, bloating, nausea, and bothersome fullness symptoms was reported by 65%–83% of respondents; 50%–59% of respondents were free from such symptoms for more than 3 h or until the next meal. Most participants (92%) reported that their quality of life improved when taking Geffer effervescent granules to treat hyperacidity symptoms. Overall, 95% of the respondents were satisfied with the effectiveness of Geffer effervescent granules on overall symptom relief. CONCLUSIONS: In Italian consumers with digestive disorders likely due to functional dyspepsia, Geffer effervescent granules was associated with rapid, complete, and durable relief of symptoms of gastric pain/cramps, acidity, bloating, nausea, and bothersome fullness; an improvement in quality of life; and a high level of consumer satisfaction.
format Online
Article
Text
id pubmed-8968989
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-89689892022-04-01 A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms Alemanni, Matteo de Salvo, Raffaella Moroni, Barbara Ehret, Andreas SAGE Open Med Original Research Article OBJECTIVES: Geffer effervescent granules (active ingredients: metoclopramide, dimethicone, and sodium bicarbonate) is an established over-the-counter medication available in Italy for the symptomatic treatment of hyperacidity (pain and/or heartburn) when accompanied by slowing of gastric transit, nausea, aerophagia, and bloating, all symptoms that can occur in functional dyspepsia and can negatively impact individuals’ quality of life. The aim of this observational study was to explore the perceived benefits of, and consumer experience with, Geffer effervescent granules used for the symptomatic treatment of digestive disorders suggestive of functional dyspepsia under real-life conditions in Italy. METHODS: Adults (aged 35–65 years) experiencing symptoms suggestive of functional dyspepsia/indigestion at least once a month and who had used Geffer effervescent granules within the previous 6 months completed an online questionnaire eliciting information on symptom relief (speed of onset and duration) and quality of life. RESULTS: Geffer effervescent granules provided rapid onset of symptom relief, with 21% of respondents perceiving an effect within 10 min and 88% reporting an improvement in overall symptoms within 30 min. A similarly rapid onset of complete resolution of gastric pain/cramps, acidity, bloating, nausea, and bothersome fullness symptoms was reported by 65%–83% of respondents; 50%–59% of respondents were free from such symptoms for more than 3 h or until the next meal. Most participants (92%) reported that their quality of life improved when taking Geffer effervescent granules to treat hyperacidity symptoms. Overall, 95% of the respondents were satisfied with the effectiveness of Geffer effervescent granules on overall symptom relief. CONCLUSIONS: In Italian consumers with digestive disorders likely due to functional dyspepsia, Geffer effervescent granules was associated with rapid, complete, and durable relief of symptoms of gastric pain/cramps, acidity, bloating, nausea, and bothersome fullness; an improvement in quality of life; and a high level of consumer satisfaction. SAGE Publications 2022-03-29 /pmc/articles/PMC8968989/ /pubmed/35371486 http://dx.doi.org/10.1177/20503121221088815 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Alemanni, Matteo
de Salvo, Raffaella
Moroni, Barbara
Ehret, Andreas
A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms
title A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms
title_full A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms
title_fullStr A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms
title_full_unstemmed A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms
title_short A real-world evidence study evaluating Geffer effervescent granules for the symptomatic relief of digestive symptoms
title_sort real-world evidence study evaluating geffer effervescent granules for the symptomatic relief of digestive symptoms
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968989/
https://www.ncbi.nlm.nih.gov/pubmed/35371486
http://dx.doi.org/10.1177/20503121221088815
work_keys_str_mv AT alemannimatteo arealworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms
AT desalvoraffaella arealworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms
AT moronibarbara arealworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms
AT ehretandreas arealworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms
AT alemannimatteo realworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms
AT desalvoraffaella realworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms
AT moronibarbara realworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms
AT ehretandreas realworldevidencestudyevaluatinggeffereffervescentgranulesforthesymptomaticreliefofdigestivesymptoms